Zhenyong Zhang
Shenyang, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Neoadjuvant immunotherapy in locally advanced head and neck squamous cell carcinoma: From oncologic outcomes to response-adaptive treatment de-escalation.
Journal: Critical reviews in oncology/hematology
Published: April 10, 2026
Unraveling the role and mechanism of mitochondria in postoperative cognitive dysfunction: a narrative review.
Journal: Journal of neuroinflammation
Published: September 25, 2024
Current status and future prospects of combined immunotherapy and epidermal growth factor receptor inhibitors in head and neck squamous cell carcinoma.
Journal: Cancer treatment reviews
Published: September 18, 2024
Creatinine-to-cystatin C ratio and body composition predict response to PD-1 inhibitors-based combination treatment in metastatic gastric cancer.
Journal: Frontiers in immunology
Published: January 02, 2024
Clinical application of immunogenic cell death inducers in cancer immunotherapy: turning cold tumors hot.
Journal: Frontiers in cell and developmental biology
Published: December 29, 2023
Correction: Advances in immunotherapy for triple-negative breast cancer.
Journal: Molecular cancer
Published: September 14, 2023
NEDD4L in human tumors: regulatory mechanisms and dual effects on anti-tumor and pro-tumor.
Journal: Frontiers in pharmacology
Published: September 10, 2023
Advances in immunotherapy for triple-negative breast cancer.
Journal: Molecular cancer
Published: April 15, 2023
Chemotherapeutic and targeted drugs-induced immunogenic cell death in cancer models and antitumor therapy: An update review.
Journal: Frontiers in pharmacology
Published: January 28, 2023
Efficacy and safety of weekly versus triweekly cisplatin treatment concomitant with radiotherapy for locally advanced nasopharyngeal carcinoma: A systematic review and pooled analysis.
Journal: Frontiers in pharmacology
Published: July 20, 2022
Corrigendum: Downregulation of GLYAT Facilitates Tumor Growth and Metastasis and Poor Clinical Outcomes Through the PI3K/AKT/Snail Pathway in Human Breast Cancer.
Journal: Frontiers in oncology
Published: October 12, 2021
Last Updated: 09/26/2026